LT3774823T - Natrio neridronato polimorfas ir jo gavimo būdas - Google Patents

Natrio neridronato polimorfas ir jo gavimo būdas

Info

Publication number
LT3774823T
LT3774823T LTEPPCT/EP2019/059026T LTEP2019059026T LT3774823T LT 3774823 T LT3774823 T LT 3774823T LT EP2019059026 T LTEP2019059026 T LT EP2019059026T LT 3774823 T LT3774823 T LT 3774823T
Authority
LT
Lithuania
Prior art keywords
polymorph
preparation
sodium neridronate
neridronate
sodium
Prior art date
Application number
LTEPPCT/EP2019/059026T
Other languages
English (en)
Inventor
Laura Dini
Fabio Neggiani
Barbara Politi
Stefano Luca Giaffreda
Alex PETROLATI
Michel CHIARUCCI
Serena Fabbroni
Kesheng Zhang
Michael Roeder
Original Assignee
Abiogen Pharma S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abiogen Pharma S.P.A. filed Critical Abiogen Pharma S.P.A.
Publication of LT3774823T publication Critical patent/LT3774823T/lt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
    • A61P5/20—Drugs for disorders of the endocrine system of the parathyroid hormones for decreasing, blocking or antagonising the activity of PTH
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/025—Purification; Separation; Stabilisation; Desodorisation of organo-phosphorus compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/3804—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
    • C07F9/3839—Polyphosphonic acids
    • C07F9/3873—Polyphosphonic acids containing nitrogen substituent, e.g. N.....H or N-hydrocarbon group which can be substituted by halogen or nitro(so), N.....O, N.....S, N.....C(=X)- (X =O, S), N.....N, N...C(=X)...N (X =O, S)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
LTEPPCT/EP2019/059026T 2018-04-10 2019-04-10 Natrio neridronato polimorfas ir jo gavimo būdas LT3774823T (lt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP18166508.4A EP3553067A1 (en) 2018-04-10 2018-04-10 Polymorph of sodium neridronate and preparation process thereof
PCT/EP2019/059026 WO2019197437A1 (en) 2018-04-10 2019-04-10 Polymorph of sodium neridronate and preparation process thereof

Publications (1)

Publication Number Publication Date
LT3774823T true LT3774823T (lt) 2022-03-10

Family

ID=62495533

Family Applications (1)

Application Number Title Priority Date Filing Date
LTEPPCT/EP2019/059026T LT3774823T (lt) 2018-04-10 2019-04-10 Natrio neridronato polimorfas ir jo gavimo būdas

Country Status (18)

Country Link
US (1) US10815257B2 (lt)
EP (2) EP3553067A1 (lt)
JP (1) JP7042359B2 (lt)
CN (1) CN112204043B (lt)
AU (1) AU2019250339B2 (lt)
CA (2) CA3096316C (lt)
CY (1) CY1125059T1 (lt)
DK (1) DK3774823T3 (lt)
ES (1) ES2908072T3 (lt)
HR (1) HRP20220248T1 (lt)
HU (1) HUE058239T2 (lt)
LT (1) LT3774823T (lt)
MX (1) MX385449B (lt)
PL (1) PL3774823T3 (lt)
PT (1) PT3774823T (lt)
SI (1) SI3774823T1 (lt)
SM (1) SMT202200166T1 (lt)
WO (1) WO2019197437A1 (lt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT201900008391A1 (it) * 2019-06-07 2020-12-07 Abiogen Pharma Spa Procedimento di preparazione del polimorfo f di sodio neridronato

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3032871A1 (de) * 1980-09-01 1982-04-15 Vysoká škola chemicko-technologická Praha, Praha 6-amino-1-hydroxyhexyliden-diphosphonsaeure, ihre salze und ein verfahren zur herstellung derselben
US4304734A (en) * 1980-10-16 1981-12-08 Vysoka Skola Chemicko-Technologicka 6-Amino-1-hydroxyhexylidene diphosphonic acid, salts and a process for production thereof
US4639338A (en) * 1984-08-06 1987-01-27 Ciba-Geigy Corporation Preparation of crystalline disodium 3-amino-1-hydroxypropane-1,1-diphosphonate pentahydrate
IT1246992B (it) 1991-01-08 1994-12-12 Gentili Ist Spa Procedimento per la preparazione di acidi difosfonici e loro sali
AU2003233569A1 (en) 2002-05-17 2003-12-02 Teva Pharmaceutical Industries Ltd. Use of certain diluents for making bisphosphonic acids
CA2656053A1 (en) 2006-07-03 2008-01-10 Generics [Uk] Limited Novel process for the preparation of bisphosphonic acids
CN101125863B (zh) 2007-08-31 2011-07-27 浙江新东港药业股份有限公司 一种阿仑膦酸新的制备方法
WO2010035664A1 (ja) 2008-09-24 2010-04-01 田辺三菱製薬株式会社 ビスホスホン酸誘導体の製法
CN104072538A (zh) 2014-07-10 2014-10-01 陕西汉江药业集团股份有限公司 一种双膦酸盐类药物的合成方法

Also Published As

Publication number Publication date
SMT202200166T1 (it) 2022-05-12
CA3096316C (en) 2022-02-22
HRP20220248T1 (hr) 2022-04-29
EP3774823A1 (en) 2021-02-17
ES2908072T3 (es) 2022-04-27
EP3774823B1 (en) 2021-12-08
SI3774823T1 (sl) 2022-04-29
EP3553067A1 (en) 2019-10-16
MX2020010744A (es) 2021-08-19
JP7042359B2 (ja) 2022-03-25
DK3774823T3 (da) 2022-02-14
CA3126088C (en) 2023-09-12
PT3774823T (pt) 2022-02-28
CA3126088A1 (en) 2019-10-17
WO2019197437A1 (en) 2019-10-17
PL3774823T3 (pl) 2022-05-02
HUE058239T2 (hu) 2022-07-28
CN112204043B (zh) 2023-11-17
MX385449B (es) 2025-03-18
AU2019250339B2 (en) 2021-07-15
CN112204043A (zh) 2021-01-08
AU2019250339A1 (en) 2020-11-26
CA3096316A1 (en) 2019-10-17
US20190308999A1 (en) 2019-10-10
US10815257B2 (en) 2020-10-27
JP2021512939A (ja) 2021-05-20
CY1125059T1 (el) 2024-02-16

Similar Documents

Publication Publication Date Title
DK3788044T3 (da) RIP1-hæmmende forbindelser og fremgangsmåder til fremstilling og anvendelse heraf
LT3601358T (lt) Anti-trem2 antikūnai ir jų naudojimo metodai
LT3565542T (lt) Polimorfinės rad1901-2hcl formos
DK3548033T3 (da) Forbindelser og deres fremgangsmåde til anvendelse
DK3310812T3 (da) Anti-HER2-antistoffer og fremgangsmåder til anvendelse
LT3490988T (lt) Naujas junginys ir gavimo būdas
MA47596A (fr) Formes cristallines du dérivé 4-pyrimidinesulfamide aprocitentan
LT4331584T (lt) Lanifibranoro deuterintų darinių terapietiniai naudojimai
DK3793960T3 (da) Kalkmælk
IL272851A (en) Methods of using dipivefrin
LT3681483T (lt) Terapinio baltymo farmacinės formos liofilizavimo būdas
IL281641A (en) Methods and uses of variant cd80 fusion proteins and related constructs
IL282813A (en) Antibody formulation
IL290185A (en) Solid state forms of risdiplam and process for preparation thereof
IL285546A (en) Compounds and methods for reducing kcnt1 expression
IL286993A (en) Voruciclib poly morphs and methods of making and using thereof
IL284327A (en) Compositions and methods for inhibiting hmgb1 expression
LT3639684T (lt) Medicininis chalatas su lengvai užrišamu raiščiu ir jo užrišimo būdas
LT3331516T (lt) Ropivakaino hidrochlorido hiperbarinis injekcinis tirpalas ir jo paruošimo procesas
IL288285A (en) Crystalline form of sofpironium bromide and preparation method thereof
LT3728334T (lt) Termiškai modifikuoto krakmolo ruošimo būdas
SI3749673T1 (sl) Kristalinična oblika biktegravir natrija
ZA202004055B (en) Salt of phenylpropionamide derivative and preparation method therefor
EP3919485A4 (en) CRYSTALS OF QUINOLINE DERIVATIVES
IL289336A (en) Compounds and methods of use thereof as antibacterial agents